Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lazarus

Showing results (801-810 of 881) with videos related to

Pageof 89
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 16, 2014
Long-term survival and late effects among one-year survivors of second allogeneic hematopoietic cell transplantation for relapsed acute leukemia and myelodysplastic syndromesChristine N Duncan, Navneet S Majhail, Ruta Brazauskas, et al.
Haematologica|September 21, 2019
Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the Acute Leukemia Working Party of the EBMTBhagirathbhai Dholaria, Bipin N Savani, Myriam Labopin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 2, 2013
Unrelated donor allogeneic transplantation after failure of autologous transplantation for acute myelogenous leukemia: a study from the center for international blood and marrow transplantation researchJames M Foran, Steven Z Pavletic, Brent R Logan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 17, 2020
The Role of Donor Lymphocyte Infusion (DLI) in Post-Hematopoietic Cell Transplant (HCT) Relapse for Chronic Myeloid Leukemia (CML) in the Tyrosine Kinase Inhibitor (TKI) EraSarah Schmidt, Ying Liu, Zhen-Huan Hu, et al.
Transplantation and Cellular Therapy|March 29, 2021
Impact of Pretransplantation Renal Dysfunction on Outcomes after Allogeneic Hematopoietic Cell TransplantationNosha Farhadfar, Ajoy Dias, Tao Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 18, 2023
Randomized Phase II Trial of Dendritic Cell/Myeloma Fusion Vaccine with Lenalidomide Maintenance after Upfront Autologous Hematopoietic Cell Transplantation for Multiple Myeloma: BMT CTN 1401David J Chung, Nina Shah, Juan Wu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 22, 2014
Second solid cancers after allogeneic hematopoietic cell transplantation using reduced-intensity conditioningOlle Ringdén, Ruta Brazauskas, Zhiwei Wang, et al.
Cancer|September 23, 2020
African Americans with translocation t(11;14) have superior survival after autologous hematopoietic cell transplantation for multiple myeloma in comparison with Whites in the United StatesTalha Badar, Parameswaran Hari, Omar Dávila, et al.
Blood Advances|April 25, 2018
Outcomes of Medicare-age eligible NHL patients receiving RIC allogeneic transplantation: a CIBMTR analysisNirav N Shah, Kwang Woo Ahn, Carlos Litovich, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 24, 2020
Collection of Peripheral Blood Progenitor Cells in 1 Day Is Associated with Decreased Donor Toxicity Compared to 2 Days in Unrelated DonorsJack W Hsu, Bronwen E Shaw, Soyoung Kim, et al.
Pageof 89

Showing results (801-810 of 881) with videos related to

Sort By:
Pageof 89
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 16, 2014
Long-term survival and late effects among one-year survivors of second allogeneic hematopoietic cell transplantation for relapsed acute leukemia and myelodysplastic syndromesChristine N Duncan, Navneet S Majhail, Ruta Brazauskas, et al.
Haematologica|September 21, 2019
Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the Acute Leukemia Working Party of the EBMTBhagirathbhai Dholaria, Bipin N Savani, Myriam Labopin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 2, 2013
Unrelated donor allogeneic transplantation after failure of autologous transplantation for acute myelogenous leukemia: a study from the center for international blood and marrow transplantation researchJames M Foran, Steven Z Pavletic, Brent R Logan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 17, 2020
The Role of Donor Lymphocyte Infusion (DLI) in Post-Hematopoietic Cell Transplant (HCT) Relapse for Chronic Myeloid Leukemia (CML) in the Tyrosine Kinase Inhibitor (TKI) EraSarah Schmidt, Ying Liu, Zhen-Huan Hu, et al.
Transplantation and Cellular Therapy|March 29, 2021
Impact of Pretransplantation Renal Dysfunction on Outcomes after Allogeneic Hematopoietic Cell TransplantationNosha Farhadfar, Ajoy Dias, Tao Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 18, 2023
Randomized Phase II Trial of Dendritic Cell/Myeloma Fusion Vaccine with Lenalidomide Maintenance after Upfront Autologous Hematopoietic Cell Transplantation for Multiple Myeloma: BMT CTN 1401David J Chung, Nina Shah, Juan Wu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 22, 2014
Second solid cancers after allogeneic hematopoietic cell transplantation using reduced-intensity conditioningOlle Ringdén, Ruta Brazauskas, Zhiwei Wang, et al.
Cancer|September 23, 2020
African Americans with translocation t(11;14) have superior survival after autologous hematopoietic cell transplantation for multiple myeloma in comparison with Whites in the United StatesTalha Badar, Parameswaran Hari, Omar Dávila, et al.
Blood Advances|April 25, 2018
Outcomes of Medicare-age eligible NHL patients receiving RIC allogeneic transplantation: a CIBMTR analysisNirav N Shah, Kwang Woo Ahn, Carlos Litovich, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 24, 2020
Collection of Peripheral Blood Progenitor Cells in 1 Day Is Associated with Decreased Donor Toxicity Compared to 2 Days in Unrelated DonorsJack W Hsu, Bronwen E Shaw, Soyoung Kim, et al.
Pageof 89